Cytotoxic properties, glycolytic effects and high-resolution respirometry mitochondrial activities of Eriocephalus racemosus against MDA-MB 231 triple-negative breast cancer
These findings support further exploration of E. racemosus as a potential therapeutic agent for TNBC, offering a promising avenue for the development of targeted treatments with minimal adverse effects.
Authors
- Lucinda Baatjies (ORCID: https://orcid.org/0000-0003-0669-9847)
- Kudakwashe Nyambo (ORCID: https://orcid.org/0000-0002-6154-2300)
- Vuyo Mavumengwana (ORCID: https://orcid.org/0000-0003-4672-6176)
- Lawrence Mabasa
- Gerald J. Maarman (ORCID: https://orcid.org/0000-0003-3336-5594)
- Francis Adu-Amankwaah (ORCID: https://orcid.org/0000-0003-0813-7135)
- Ndivhuwo Tshililo
- Candice Februarie
Institutions
- South African Medical Research Council (ZA)
- Stellenbosch University (ZA)
Publication Details
- Journal
- BMC Complementary Medicine and Therapies
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1186/s12906-024-04615-x
- Citations
- 1
- Primary Topic
- Bioactive Compounds and Antitumor Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.35
Funders
- South African Medical Research Council
- Universiteit Stellenbosch
- Medical Research Council